logo

For the Inventor, By the Inventor

Kapellen, Belgium

Walter Boudewijn Leopold Wouters

This inventor holds 19 USPTO granted patents and 2 published patent applications and 8 EPO patents, primarily in PARP Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica, Other. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Boudewijn Leopold Wouters. Retrieved from https://idiyas.com/inventor/walter-boudewijn-leopold-wouters

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 26.3


Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Beerse, BE (2015)
  • Kapellen, BE (2001 - 2018)

Company Filing History:

goldMedal17 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal1 out of 32 
 
Janssen Pharmaceutica
 patents
bronzeMedal1 out of 834,601 
Other
 patents

Years Active: 2001-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
PARP Inhibitors
Quinazolinone Derivatives
Poly(ADP-Ribose) Polymerase
Quinazolinedione Derivatives
2-Quinolinones
2-Quinoxalinones
6-Alkenyl Substituents
6-Phenylalkyl Substituents
Phthalazine Derivatives
Substituted Compounds
Cyclohexylalkyl Substituents
RAMBA
19 patents (USPTO):Explore Patents
1. 10150757 - Quinazolinone derivatives as PARP inhibitors (2018-12-11),
2. 9522905 - Quinazolinone derivatives as PARP inhibitors (2016-12-20),
3. 9255080 - Quinazolinedione derivatives as PARP inhibitors (2016-02-09),
4. 9115084 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2015-08-25),
5. 8623884 - Quinazolinedione derivatives as PARP inhibitors (2014-01-07),
6. 8623872 - Quinazolinone derivatives as PARP inhibitors (2014-01-07),
7. 8524714 - 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2013-09-03),
8. 8450486 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2013-05-28),
9. 8188103 - Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors (2012-05-29),
10. 8080557 - Quinazolinedione derivatives as PARP inhibitors (2011-12-20),
11. 8071612 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2011-12-06),
12. 7928104 - 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2011-04-19),
13. 7879857 - 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors (2011-02-01),
14. 7855207 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors (2010-12-21),
15. 7803795 - Phthalazine derivatives as parp inhibitors (2010-09-28),

Title: Innovator Spotlight: Walter Boudewijn Leopold Wouters

Introduction: Walter Boudewijn Leopold Wouters, based in Kapellen, Belgium, is a notable inventor with a remarkable portfolio of 19 patents. His contributions, particularly in the field of pharmaceuticals, showcase his dedication to advancing medical science through innovation.

Latest Patents: Among his most recent inventions are the quinazolinone derivatives identified as PARP inhibitors. These compounds, represented by the formula (I), demonstrate a promising potential as therapeutic agents. The patents detail their specific chemical structures and their pharmaceutical applications, indicating a significant leap forward in the treatment of various diseases.

Career Highlights: Wouters’ career includes notable tenures at Janssen Pharmaceutica NV, where he honed his expertise in drug development and innovative pharmaceutical solutions. His work has notably impacted the industry, leading to advancements that benefit both medical professionals and patients alike.

Collaborations: Throughout his career, Wouters has collaborated with esteemed colleagues such as Jacobus Alphonsus Josephus van Dun and Maria Victorina Francisca Somers. These collaborations have further enriched his work and have contributed to his success in the patenting process.

Conclusion: Walter Boudewijn Leopold Wouters stands out as a prominent figure in the world of invention, with a strong focus on pharmaceutical advancements. His work not only reflects individual brilliance but also underscores the importance of collaboration and innovation in achieving significant breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…